Table 2.

Studies reporting mGFR values in term-born neonates

Author(s), Year	Neonates Included (n)	Measurements Included (n)	Age Range (d)	Health Status	GFR Marker Used	Method of Presenting GFR	Individual or Aggregated Data (n data points for aggregated data)	City and Country of Origin
Al-Dahhan et al., 198353	6	6	5–6	Healthy	CrCLa	ml/min per 1.73 m2	Individual	London, United Kingdom
Aperia et al., 197254	5	5	3–15	Healthy	Inulin	ml/min per 1.73 m2	Individual	Stockholm, Sweden
Aperia et al., 197555	9	9	3–21	Disease without effect on GFR	Inulin	ml/min per 1.73 m2	Individual	Stockholm, Sweden
Aperia et al., 198156	15	15	2–5	Healthy	Inulin	ml/min per 1.73 m2	Individual	Stockholm, Sweden
Arant, 197857	26	26	1	Healthy	CrCLa	ml/min + weight	Aggregated (1)	Memphis, United States
Boehm et al., 198458	44	44	2–19	Healthy	Mannitol	ml/min per 1.73 m2	Individual	Leipzig, Germany
Broberger, 197359	15	15	3–14	Not mentioned	Inulin	ml/min per 1.73 m2	Individual	Stockholm, Sweden
Broberger and Aperia, 197960	14	14	4–5	Healthy	Inulin	ml/min per 1.73 m2	Aggregated (2)	Stockholm, Sweden
Brodehl and Gellissen, 196861	5	5	16–26	Disease without effect on GFR	Inulin	ml/min per 1.73 m2	Individual	Bonn, Germany
Brodehl et al., 198262	8	8	14–27	Disease without effect on GFR	Inulin	ml/min per 1.73 m2	Individual	Hannover, Germany
Bueva and Guignard, 199442	28	46	1–16	Healthy	CrCLb	ml/min per 1.73 m2	Aggregated (3)	Lausanne, Switzerland
Casimiro Pantoja et al., 197763	7	7	4–7	Healthy	Inulin	ml/min per 1.73 m2	Individual	Unclear, Mexican journal
Coulthard, 198564	5	5	2–6	Healthy	Inulin	ml/min + weight	Individual	Newcastle upon Tyne, United Kingdom
Dean and McCance, 194765	8	8	2–8	Disease with possible effect on GFR	Inulin	ml/min per 1.73 m2	Individual	Cambridge, United Kingdom
Edelmann et al., 196066	13	13	1–28	Not mentioned	Inulin	ml/min per 1.73 m2	Individual	New York City, United States
Fawer et al., 197918	13	13	1–19	Healthy	Inulin	ml/min per m2	Individual	Lausanne, Switzerland
Fawer et al., 197967	31	31	1–9	Disease with possible effect on GFR	Inulin	ml/min per m2	Aggregated (2)	Lausanne, Switzerland
Friederiszick, 195468	1	1	21	Healthy	Inulin	ml/min per 1.73 m2	Individual	Mainz, Germany
Gekle et al., 196769	3	3	14–21	Healthy	Inulin	ml/min per 1.73 m2	Individual	Würzburg, Germany
Godard et al., 197970	19	19	1–8	Healthy	CrCLa	ml/min per 1.73 m2	Aggregated (2)	Geneva, Switzerland
Gordjani et al., 198871	39	39	1–9	Healthy	CrCLb	ml/min per 1.73 m2	Aggregated (4)	Marburg, Switzerland
Gubhaju et al., 201443	20	31	3–28	Healthy	CrCLc	ml/min per m2	Aggregated (2)	Brisbane, Australia
Guignard et al., 197517	10	10	1–19	Disease without effect on GFR	Inulin	ml/min per m2	Individual	Lausanne, Switzerland
Haimi-Cohen et al., 199772	37	37	3	Disease with possible effect on GFR/healthy	CrCLb	ml/min per 1.73 m2	Aggregated (2)	Tel Aviv, Israel
Kapoor et al., 198873	20	20	1	Healthy	CrCLb	ml/min per 1.73 m2	Aggregated (1)	Lucknow, India
Leake et al., 197641	6	6	7–28	Healthy	Inulin	ml/min per 1.73 m2	Individual	Torrance, United States
Leake and Trygstad, 197774	14	14	0–3	Disease with possible effect on GFR/healthy	Inulin	ml/min + weight	Individual	Torrance, United States
Leititis et al., 198744	82	82	1–9	Healthy	CrCLc	ml/min per 1.73 m2	Aggregated (4)	Marburg, Germany
Maruyama, 196575	7	7	4–27	Healthy	CrCLa	ml/min per 1.73 m2	Individual	City unknown, Japan
McCrory et al., 195276	14	14	5–19	Disease with possible effect on GFR/healthy	Inulin	ml/min + BSA	Individual	New York City, United States
Oh et al., 196677	66	66	0–5	Healthy	Inulin	ml/min + weight and height	Individual	Stockholm, Sweden
Olavarria et al., 198678	20	20	1	Healthy	CrCLb	ml/min per 1.73 m2	Aggregated (1)	Valdivia, Chile
Nair et al., 198779	48	48	1–14	Healthy	CrCLb	ml/min per 1.73 m2	Aggregated (3)	Hyderabad, India
Passwell et al., 197480	15	15	3–4	Healthy	CrCLc	ml/min + weight	Individual	Tel-Hashomer, Israel
Peters et al., 199481	6	6	9–28	Disease without effect on GFR	51Cr-EDTA	ml/min per 1.73 m2	Individual	London, United Kingdom
Richmond et al., 195182	4	4	3–24	Healthy	Inulin	ml/min per 1.73 m2	Individual	Chicago, United States
Robinson et al., 199083	2	2	1	Healthy	Inulin	ml/min + weight	Individual	Iowa city, United States
Rubin et al., 194916	11	11	2–22	Healthy	Mannitol	ml/min per 1.73 m2	Individual	Buffalo, United States
Sawa et al., 197484	30	60	1–4	Healthy	CrCLa	ml/min per 1.73 m2	Aggregated (2)	Warsaw, Poland
Schwartz et al., 198430	9	9	5	Healthy	CrCLa	ml/min per 1.73 m2	Aggregated (1)	New York City, United States
Sertel and Scopes, 197385	17	25	1–6	Healthy	CrCLb	ml/min per 1.73 m2	Individual	London, United Kingdom
Siegel and Oh, 197686	21	21	1	Healthy	CrCLa	ml/min per 1.73 m2	Individual	Torrance, United States
Stapleton, 198387	15	15	1	Healthy	CrCLa	ml/min + weight	Aggregated (1)	Memphis, United States
Sulyok and Guignard, 199088	22	22	7	Healthy	CrCLb	ml/min per 1.73 m2	Aggregated (2)	Lausanne, Switzerland
Vio et al., 198789	14	14	1	Healthy	CrCLb	ml/min per 1.73 m2	Aggregated (1)	Valdivia, Chile
Watanabe et al., 198990	10	70	1–7	Healthy	CrCLa	ml/min + weight	Aggregated (7)	Osaka, Japan
West et al., 194891	4	4	8–25	Disease without effect on GFR	Mannitol	ml/min per 1.73 m2	Individual	New York City, United States
Winberg, 195992	13	13	4–12	Disease without effect on GFR	CrCLa	ml/min per 1.73 m2	Individual	Stockholm, Sweden
Total (N=48)	881	978	0–28

^aCompensated Jaffe method used for creatinine determination.

^bJaffe method used for creatinine determination.

^cUnkown method used for creatinine determination.